Telix Pharmaceuticals TLX
NASDAQ TLX
$9.51 +0.25 (+2.70%)
At close: Oct 29, 2026 · 4:00 PM EDT

Telix Pharmaceuticals (TLX) Liabilities and Shareholders Equity (2023 - 2026)

Updated

Telix Pharmaceuticals' Liabilities and Shareholders Equity came in at $1.36 billion for the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Telix Pharmaceuticals' Liabilities and Shareholders Equity was $1.16 billion, up 17.4% from the prior year.

  • Going back by year, Liabilities and Shareholders Equity was $991.68 million in the year ended Dec 31, 2024 (+275.2%) and $264.27 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,264.17 Bn 1,237.79 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 660.04 Bn 579.90 Bn 17.30 Bn 197.43 Bn
3 AbbVie 521.06 Bn 494.17 Bn 12.70 Bn 135.12 Bn
4 Merck 370.60 Bn 370.60 Bn - -
5 Novartis Ag 311.97 Bn 285.20 Bn - -
6 Astrazeneca 288.69 Bn 262.37 Bn 12.86 Bn 115.83 Bn
7 Amgen 252.29 Bn 207.69 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 213.47 Bn 213.47 Bn - -
9 Pfizer 173.68 Bn 120.32 Bn 10.94 Bn 201.13 Bn
10 Telix Pharmaceuticals 3.07 Bn 2.03 Bn - 1.36 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.36 Bn
Dec 31, 2025 1.16 Bn
Dec 31, 2024 943.22 Mn
Dec 31, 2023 277.12 Mn
API Access

Telix Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TLX&period=max&api_key=YOUR_API_KEY